Focal Segmental Glomerulosclerosis (FSGS):グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Focal Segmental Glomerulosclerosis (FSGS) 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Focal Segmental Glomerulosclerosis (FSGS) 22
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials 26
Prominent Drug Comparison 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Sanofi 28
Clinical Trial Overview of Sanofi 28
Retrophin, LLC 29
Clinical Trial Overview of Retrophin, LLC 29
FibroGen, Inc. 30
Clinical Trial Overview of FibroGen, Inc. 30
Clinical Trial Overview of Top Institutes / Government 31
North Shore Long Island Jewish Health System 31
Clinical Trial Overview of North Shore Long Island Jewish Health System 31
Nanjing University 32
Clinical Trial Overview of Nanjing University 32
Fukuoka University 33
Clinical Trial Overview of Fukuoka University 33
The Children’s Hospital of Philadelphia 34
Clinical Trial Overview of The Children’s Hospital of Philadelphia 34
Hospital Authority 35
Clinical Trial Overview of Hospital Authority 35
Nanjing Medical University 36
Clinical Trial Overview of Nanjing Medical University 36
Columbia University 37
Clinical Trial Overview of Columbia University 37
University of Sao Paulo 38
Clinical Trial Overview of University of Sao Paulo 38
New York University School of Medicine 39
Clinical Trial Overview of New York University School of Medicine 39
Sunnybrook Health Sciences Centre 40
Clinical Trial Overview of Sunnybrook Health Sciences Centre 40
Five Key Clinical Profiles 41
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Disclaimer 65
Source 66


【レポート販売概要】

■ タイトル:Focal Segmental Glomerulosclerosis (FSGS):グローバル臨床試験レビューH2, 2013
■ 英文:Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2013
■ 発行日:2013年11月15日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162703
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。